This compound is a pharmaceutical intermediate featuring a piperazine ring and a trifluoromethyl-substituted aniline moiety. It is primarily used in the synthesis of other pharmaceutical compounds.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 694499-26-8
Ethyl hydrazinoacetate hydrochloride
pharmaceutical intermediate
(1R,2R,3R,5S)-2,6,6-Trimethylbicyclo[3.1.1]heptan-3-amine
pharmaceutical intermediate
3'-Chloro-4'-aminoacetophenone
pharmaceutical intermediate
Ethyl N-(diphenylmethylene)glycinate
pharmaceutical intermediate
1-Nitroso-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine
nitrosamine impurity standard
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride
pharmaceutical intermediate
4-(4-Methylpiperazinylmethyl)benzoyl chloride dihydrochloride
pharmaceutical intermediate
4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)aniline
ZMWAZMYBMAAMAW-UHFFFAOYSA-N
CN1CCN(CC1)CC2=C(C=C(C=C2)N)C(F)(F)F